Küçün Tugberk, Ahiskalioglu Elif Oral, Yayik Ahmet Murat, Aydin Muhammed Enes, Küçün Neslihan, Ulas Ali Bilal, Ahiskalioglu Ali
Department of Anaesthesiology and Reanimation, Ataturk University School of Medicine, 25070, Erzurum, Turkey.
Department of Thoracic Surgery, Ataturk University School of Medicine, Erzurum, Turkey.
Gen Thorac Cardiovasc Surg. 2025 Jun 3. doi: 10.1007/s11748-025-02165-8.
The effect of erector spinae plane block and systemic lidocaine infusion for major thoracotomy is still unclear. Therefore, we aimed to compare ESPB, systemic lidocaine and standard analgesia in patients who undergoing major thoracotomy.
Patients with ASA I-III, aged between 18 and 65 years scheduled for major thoracotomy were enrolled. Patients were randomly assigned to receive an intravenous (IV) infusion of placebo combined with ESP block using placebo (group P), ESP block with 0.25% bupivacaine combined with IV placebo (group ESPB), or IV-lidocaine combined with ESP-block using placebo (group L). The primary outcome was postoperative (24 h) total opioid consumption. The secondary outcomes were VAS scores, rescue analgesia, and intraoperative remifentanil consumption.
Resting VAS scores were significantly lower in both groups ESPB and L compared to group P during the first four postoperative hours. Similarly, dynamic VAS scores were lower in group ESPB and group L compared to group P during the first two postoperative hours (p < 0.05). ESP block was not found to be superior to systemic lidocaine in reducing morphine requirements during the first 24 h (30.25 ± 5.1 vs. 28.7 ± 3.1 respectively, p = 0.567). Additionally, the difference in morphine consumption between group P and either ESP-block or systemic lidocaine groups was minimal, amounting to only 3-4.5 mg. However, the requirement for rescue analgesia was significantly lower in both groups ESPB and L compared to group P (p < 0.05). There was no difference between groups ESPB and L in terms of rescue analgesia requirement.
ESP block did not demonstrate superior postoperative analgesic efficacy compared to systemic lidocaine in patients undergoing major thoracotomy.
竖脊肌平面阻滞与静脉输注利多卡因用于开胸大手术的效果仍不明确。因此,我们旨在比较接受开胸大手术患者的竖脊肌平面阻滞(ESPB)、静脉输注利多卡因和标准镇痛方法。
纳入年龄在18至65岁、美国麻醉医师协会(ASA)分级为I - III级且计划行开胸大手术的患者。患者被随机分配接受静脉输注安慰剂联合使用安慰剂的ESPB阻滞(P组)、0.25%布比卡因的ESPB阻滞联合静脉输注安慰剂(ESPB组)或静脉输注利多卡因联合使用安慰剂的ESPB阻滞(L组)。主要结局指标为术后(24小时)阿片类药物总消耗量。次要结局指标包括视觉模拟评分(VAS)、补救性镇痛及术中瑞芬太尼消耗量。
术后前4小时,ESPB组和L组的静息VAS评分均显著低于P组。同样,术后前2小时,ESPB组和L组的动态VAS评分低于P组(p < 0.05)。在术后24小时内减轻吗啡需求量方面,未发现ESPB阻滞优于静脉输注利多卡因(分别为30.25 ± 5.1 vs. 28.7 ± 3.1,p = 0.567)。此外,P组与ESPB阻滞组或静脉输注利多卡因组之间的吗啡消耗量差异极小,仅为3 - 4.5毫克。然而,ESPB组和L组的补救性镇痛需求量均显著低于P组(p < 0.05)。ESPB组和L组在补救性镇痛需求方面无差异。
对于接受开胸大手术的患者,ESPB阻滞在术后镇痛效果上并未显示出优于静脉输注利多卡因。